Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flu Fix
- Development stage
- Unknown
- Lead developer
- Genexa
- Administration
- Oral
01
Overview
Flu Fix is an over-the-counter, non-drowsy homeopathic medicine developed by Genexa. It is formulated as organic chewable tablets to address multi-symptom flu-related indications, including body aches, headache, fever, chills, fatigue, congestion, and sore throat. The product features a blend of active homeopathic ingredients, such as Aconitum napellus, Allium cepa, Anas barbariae, Bryonia alba, Echinacea angustifolia, Eupatorium perfoliatum, Euphrasia officinalis, Gelsemium sempervirens, Ipecacuanha, Nux vomica, Pulsatilla, and Rhus toxicodendron, without artificial dyes, preservatives, or common allergens.
- Brand names
- Flu Fix
- Other names
- Genexa Flu Fix
Beyond the preview
Go deeper on Flu Fix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flu Fix.